Correlation Between Catalyst Pharmaceuticals and Triad Business

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Triad Business at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Triad Business into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Triad Business Bank, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Triad Business and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Triad Business. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Triad Business.

Diversification Opportunities for Catalyst Pharmaceuticals and Triad Business

-0.06

Correlation Coefficient

Catalyst Pharmaceuticals  Triad Business

Good diversification

The 3 months correlation between Catalyst and Triad is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Triad Business Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Triad Business Bank and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Triad Business. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Triad Business Bank has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Triad Business go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Triad Business

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 5.25 times more return on investment than Triad Business. However, Catalyst Pharmaceuticals is 5.25 times more volatile than Triad Business Bank. It trades about 0.05 of its potential returns per unit of risk. Triad Business Bank is currently generating about 0.02 per unit of risk. If you would invest  2,127  in Catalyst Pharmaceuticals on December 20, 2024 and sell it today you would earn a total of  133.00  from holding Catalyst Pharmaceuticals or generate 6.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	93.65%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Triad Business Bank

Catalyst Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Triad Business Bank

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Triad Business Bank are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental drivers, Triad Business is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Catalyst Pharmaceuticals and Triad Business

The main advantage of trading using opposite Catalyst Pharmaceuticals and Triad Business positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Triad Business can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Triad Business will offset losses from the drop in Triad Business' long position.

The idea behind Catalyst Pharmaceuticals and Triad Business Bank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.